Literature DB >> 28104672

Modulating the malignancy of Hox proteins.

Michael Kyba1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28104672      PMCID： PMC5248935          DOI： 10.1182/blood-2016-11-751909

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

Review 1.  Hox genes in hematopoiesis and leukemogenesis.

Authors:  B Argiropoulos; R K Humphries
Journal:  Oncogene       Date:  2007-10-15       Impact factor: 9.867

2.  Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells.

Authors:  Motohiko Oshima; Mitsuhiro Endoh; Takaho A Endo; Tetsuro Toyoda; Yaeko Nakajima-Takagi; Fumihiro Sugiyama; Haruhiko Koseki; Michael Kyba; Atsushi Iwama; Mitsujiro Osawa
Journal:  Blood       Date:  2011-02-22       Impact factor: 22.113

3.  Controlled stem cell amplification by HOXB4 depends on its unique proline-rich region near the N terminus.

Authors:  Monica Cusan; Naidu M Vegi; Medhanie A Mulaw; Shiva Bamezai; Lisa M Kaiser; Aniruddha J Deshpande; Philipp A Greif; Leticia Quintanilla-Fend; Stefanie Göllner; Carsten Müller-Tidow; Keith R Humphries; Scott A Armstrong; Wolfgang Hiddemann; Michaela Feuring-Buske; Christian Buske
Journal:  Blood       Date:  2016-11-08       Impact factor: 22.113

Review 4.  Hox genes in vertebrate development.

Authors:  R Krumlauf
Journal:  Cell       Date:  1994-07-29       Impact factor: 41.582

5.  HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors.

Authors:  Michael Kyba; Rita C R Perlingeiro; George Q Daley
Journal:  Cell       Date:  2002-04-05       Impact factor: 41.582

6.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.

Authors:  T R Golub; D K Slonim; P Tamayo; C Huard; M Gaasenbeek; J P Mesirov; H Coller; M L Loh; J R Downing; M A Caligiuri; C D Bloomfield; E S Lander
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

7.  Downstream targets of HOXB4 in a cell line model of primitive hematopoietic progenitor cells.

Authors:  Han M Lee; Hui Zhang; Vincent Schulz; David P Tuck; Bernard G Forget
Journal:  Blood       Date:  2010-04-19       Impact factor: 22.113

8.  Enhanced in vivo regenerative potential of HOXB4-transduced hematopoietic stem cells with regulation of their pool size.

Authors:  U Thorsteinsdottir; G Sauvageau; R K Humphries
Journal:  Blood       Date:  1999-10-15       Impact factor: 22.113

9.  In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein.

Authors:  Jana Krosl; Pamela Austin; Nathalie Beslu; Evert Kroon; R Keith Humphries; Guy Sauvageau
Journal:  Nat Med       Date:  2003-10-26       Impact factor: 53.440

10.  Purified recombinant TAT-homeobox B4 expands CD34(+) umbilical cord blood and peripheral blood progenitor cells ex vivo.

Authors:  Chi-Hung Huang; Po-Min Chen; Tsung-Chi Lu; Wen-Mei Kung; Tzeon-Jye Chiou; Muh-Hwa Yang; Jung-Yie Kao; Kou-Juey Wu
Journal:  Tissue Eng Part C Methods       Date:  2010-06       Impact factor: 3.056
  10 in total
  2 in total

1.  LncRNA HOXA-AS3 confers cisplatin resistance by interacting with HOXA3 in non-small-cell lung carcinoma cells.

Authors:  Shuang Lin; Rui Zhang; Xiaoxia An; Zhoubin Li; Cheng Fang; Bo Pan; Wei Chen; Guodong Xu; Weili Han
Journal:  Oncogenesis       Date:  2019-10-15       Impact factor: 7.485

2.  microRNA-196a-5p inhibits testicular germ cell tumor progression via NR6A1/E-cadherin axis.

Authors:  Xiaowen Liu; Ziling Fan; Ye Li; Zhilan Li; Zhuan Zhou; Xuehui Yu; Jingyu Wan; Ziqian Min; Lifang Yang; Dan Li
Journal:  Cancer Med       Date:  2020-10-09       Impact factor: 4.452
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.